1 / 58

Functional Neurosurgery and Anesthetic Considerations

Functional Neurosurgery and Anesthetic Considerations. Susan M Ryan, PhD, MD Associate Clinical Professor Department of Anesthesia, UCSF 2006. What is Functional Neurosurgery?. “Neurosurgery intended to improve or restore function by altering underlying physiology”.

shaw
Download Presentation

Functional Neurosurgery and Anesthetic Considerations

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Functional Neurosurgery and Anesthetic Considerations Susan M Ryan, PhD, MD Associate Clinical Professor Department of Anesthesia, UCSF 2006

  2. What is Functional Neurosurgery? “Neurosurgery intended to improve or restore function by altering underlying physiology”

  3. Areas of Functional Neurosurgery • Movement disorders • Seizures • Pain syndromes • Psychiatric disorders • Peripheral nerve injuries

  4. Areas of Expansion • Movement disorders • Seizures • Psychiatric disorders

  5. Neurosurgical Techniques • Deep brain stimulation (DBS) • Selective ablation electrodes • Implantation viral vectors stem cells • Cranial nerve/ peripheral electrical stimulation

  6. Functional Neurosurgery • Began in mid-1900’s • Eclipsed by effective medications • Now: Non-responders Advanced cases

  7. Neurosurgical Techniques • Deep brain stimulation Best established use: Parkinson’s Disease • Vagal nerve stimulation Best established use: Seizure disorders

  8. DBS/VNS Studies in Progress • Obesity • Fibromyalgia • Cluster headache • Tourette’s Syndrome • Depression • Obsessive Compulsive Disorder

  9. DBS for Parkinson’s Disease

  10. Clinical Features • ‘Pill-rolling’ tremor • Masked faces • ‘Cog-wheel’ rigidity • Festinating gate • Bradykinesia

  11. Pathologic Features • Progressive neuronal death • Dopamine neurons of substantia nigra • Non- dopamine populations in CNS and PNS • Bulbar function • Sympathetic chain • Parasympathetics of the gut

  12. Basal Ganglia in PD

  13. Treatment • Medications • L-dopa + periph. inhibitor (Sinamet) • Dopamine agonists • MAO inhibitors • COMT inhibitors • Amantadine

  14. DBS Surgery • Goal: Improvement in PD symptoms • Tremor • Rigidity • Hypokinesia • Gait • Balance

  15. DBS Surgery • Placement of stereotactic frame prior to procedure • MRI to confirm coordinates

  16. DBS Surgery • Stereotactic head frame attached to bed • Pt placed in sitting position

  17. DBS Stereotactic Surgery • Drill hole in skull to allow electrode placement for recording & stimulation

  18. DBS Stereotactic Surgery • Electrode passed slowly to record single cells in nucleus of interest

  19. DBS Stereotactic Surgery • Visual and auditory feedback of cell location and characteristics

  20. DBS Stereotactic Surgery • Listening for cell response during leg movement

  21. DBS Surgery • Find best location within the nucleus • Place stimulating electrode • Close burr hole, remove frame • Induce general anesthesia • Tunnel leads • Place generator in upper chest wall • Wait to activate stimulator in outpatient setting

  22. Anesthesia: DBS Generator placement • General anesthesia for generator placement • No particular anesthetic Propofol or inhaled agent work well Avoid dopamine antagonists Avoid demerol Muscle relaxants OK • Prevent or treat emergence hypertension • Not much pain in post-op setting

  23. PD: Specific Issues • Risk of exacerbation Consider intraoperative continuation of medications • Hemodynamics may be labile Degeneration of sympathetic ganglia Dopamine-related hypotension, hypovolemia

  24. PD: Specific Issues • Airway or pulmonary compromise • Upper airway obstruction • Dysarthria and history of choking • Restrictive ventilatory pattern • Aspiration risk

  25. Patients with Existing DBS • DBS is usually on 24/7 for PD pts • May be off at night in other conditions • Consider turning off prior to surgery

  26. DBS: Surgical Risks • Intracerebral hemorrhage • Venous air embolism • Emotional lability

  27. DBS: Surgical Risks Intracerebral hemorrhage • Monitor patient for neurologic changes • Risk: 1.6% per lead • Avoid hypertension Keep SBP < 140 Consider arterial line Antihypertensives: labetalol, hydralazine

  28. DBS: Surgical Risks Venous air embolism • Early detection • Communicate with surgeon • Support blood pressure • Provide O2 • Airway plan

  29. DBS: Surgical Risks Emotional Lability • Usually no treatment needed • Consider sedation PRN

  30. DBS Outcomes Bilateral DBS of STN: • N = 49 • Assessed at 1,3, and 5 years • Assessed on and off meds and stimulation (Krack, et al, NEJM 349, 2003)

  31. DBS Outcomes • Stimulation alone: significant improvement • Synergy between meds and stimulation • Allows decrease in medication doses • Improvement in L-dopa dyskinesias • Akinesia, speech, and freezing of gait all worsened (Krack, et al, NEJM 349, 2003)

  32. DBS vs Medical Therapy • Randomized-pair trial: • DBS + optimized medical tx • Optimized medical tx • 75% of pairs favored DBS + meds Quality of life Severity of motor sxs off medication (Deuschl et al, NEJM, 355, 2006)

  33. DBS: other motor diseases • Essential tremor • Dystonia • More sedation during MRI

  34. DBS and Tourette’s • Motor/speech tics • Up to 1% school age children • 1/3 persist into adulthood

  35. DBS for Tourette’s(Visser-Vandewalle, J. Neurosurg 99: 2003)

  36. DBS and Psychiatric Disease • Depression • Pilot in 2005 • 4/6 patients improved >50% on testing • Currently at least 3 ongoing NIH trials • 10 to 20 patients per study

  37. Vagus Nerve Stimulation

  38. Vagus: Mixed Sensory and Motor • 20% efferent: parasympathetic control of the heart and gut viscera • 80% afferent: extensive connections to limbic and higher cortical systems • Animal studies VNS: EEG changes and seizure cessation

  39. Vagal Nerve Stimulation • Approved device made by Cyberonics • Chronic, intermittent stimulation to cervical vagus • Prevents and aborts seizures

  40. Vagal Nerve Stimulation • Typical settings: • Automatic: 30 sec stimulation q 5 min • Additional manual: if pt feels aura, may wave wand over generator to activate stimulator

  41. Vagal Nerve Stimulation • Results from 3 studies: • Significant decrease in seizures: 24%-35% • Controls: low-level stimulation • Seizure frequency decreased further over time • Decreased medication doses

  42. VNS Surgery • Performed under general anesthesia • Leads wrapped around L vagus in neck • Only L, and only unilateral • Generator placed upper left chest

  43. Final Electrode/tether Placement Anchor Tether Negative Electrode Positive Electrode

  44. VNS Surgery • Possible intraop complications with lead testing: • Arrhythmias- transient sinus arrest • Labile hemodynamics • Airway obstruction (vocal cord stimulation)- if not intubated

  45. VNS Surgery • Surgical complications: • Infection: 2.9% • Hoarseness or temporary vocal cord paralysis: 0.7% • Hypesthesia or lower left facial paralysis: 0.7%

  46. VNS Surgery: Chronic Side Effects • Hoarseness • Cough • Paresthesias • Dyspepsia • Disrupted sleep • Worsening sleep apnea

  47. VNS: Anesthesia • Pre-op considerations: • Take usual seizure medications • CBC, electrolytes • EKG • cardiac medications?

More Related